Pediatric Clinical Trials Study

CHAPERONE – Myopia Treatment Study

Vanderbilt researchers are looking for healthy, nearsighted (myopic) children between the ages of 3-12 to participate in a study. The study is being done to see if low-dose eye drops of a drug called atropine can help prevent myopia (nearsightedness) from getting worse. Participants will be randomized to either 0.01% atropine eye drops, 0.1% atropine drops, or placebo eye drops. Participants will use the study eye drop in each eye nightly for four years.
Study visits start with an Enrollment Visit and a Randomization Vvisit. Then, participants will see their study doctor every 6 months for about 4 years. Each visit will be about 1 to 1.5 hours. Study visits are no-cost, and participants are compensated for their time. Glasses may also be provided by the study.
If you are interested in learning more about this study, please email Saige Wilkins or call 615 936-1474.



Myopia Treatment Study

Vanderbilt Eye Institute is now enrolling children in a new clinical trial of low-dose atropine for the treatment of myopia progression. Children in this study will use a microdoser to mist the eye daily with study medication instead of using a traditional eyedrop bottle.

If you are interested in learning more about this study, please call Saige Wilkins at 615 936-1474 or send an email to

Please CLICK HERE to view the brochure.